Market capitalization | $7.83b |
Enterprise Value | $40.30b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 0.27 |
P/S ratio (TTM) P/S ratio | 0.05 |
P/B ratio (TTM) P/B ratio | 0.75 |
Dividend yield | 13.58% |
Last dividend (FY24) | $1.23 |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
21 Analysts have issued a Walgreens Boots Alliance forecast:
21 Analysts have issued a Walgreens Boots Alliance forecast:
Aug '24 |
+/-
%
|
||
Revenue | 147,657 147,657 |
6%
6%
|
|
Gross Profit | 24,064 24,064 |
3%
3%
|
|
EBITDA | 4,236 4,236 |
3%
3%
|
EBIT (Operating Income) EBIT | 1,778 1,778 |
16%
16%
|
Net Profit | -8,636 -8,636 |
180%
180%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Walgreens Boots Alliance, Inc. engages in the provision of drug store services. The company operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment engages in pharmacy-led health and beauty retail businesses, which sells its products under brand names Walgreens and Duane Reade. The Retail Pharmacy International segment offers retail stores, which sells products of brands No7, Boots Pharmaceuticals, Botanics, Liz Earle, and Soap & Glory. The Pharmaceutical Wholesale segment supplies medicines, other healthcare products and related services to pharmacies, doctors, health centers, and hospitals. The company was founded in 1901 and is headquartered in Deerfield, IL.
Head office | United States |
CEO | Timothy Wentworth |
Employees | 312,000 |
Founded | 1909 |
Website | www.walgreensbootsalliance.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.